Talis Biomedical (TLIS) Competitors

Astrotech (NASDAQ:ASTC) and Talis Biomedical (NASDAQ:TLIS) are both small-cap aerospace companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Is ASTC or TLIS more profitable?

Astrotech has a net margin of -945.17% compared to Talis Biomedical's net margin of -5,784.73%. Astrotech's return on equity of -33.26% beat Talis Biomedical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrotech	-945.17%	-33.26%	-31.03%
Talis Biomedical	-5,784.73%	-79.74%	-57.16%

Which has preferable valuation & earnings, ASTC or TLIS?

Astrotech has higher revenue and earnings than Talis Biomedical. Astrotech is trading at a lower price-to-earnings ratio than Talis Biomedical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrotech	$1.27M	9.72	-$11.67M	-$7.34	-0.99
Talis Biomedical	$300K	10.50	-$62.01M	-$28.02	-0.06

Which has more risk and volatility, ASTC or TLIS?

Astrotech has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500.

Do insiders and institutionals have more ownership in ASTC or TLIS?

24.4% of Astrotech shares are held by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are held by institutional investors. 14.9% of Astrotech shares are held by insiders. Comparatively, 46.0% of Talis Biomedical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media favor ASTC or TLIS?

In the previous week, Astrotech had 1 more articles in the media than Talis Biomedical. MarketBeat recorded 1 mentions for Astrotech and 0 mentions for Talis Biomedical. Astrotech's average media sentiment score of 0.00 equaled Talis Biomedical'saverage media sentiment score.

Company	Overall Sentiment
Astrotech	Neutral
Talis Biomedical	Neutral

Does the MarketBeat Community prefer ASTC or TLIS?

Astrotech received 119 more outperform votes than Talis Biomedical when rated by MarketBeat users. Likewise, 56.64% of users gave Astrotech an outperform vote while only 37.50% of users gave Talis Biomedical an outperform vote.

Company	Underperform	Outperform
Astrotech	Outperform Votes 128 56.64%	Underperform Votes 98 43.36%
Talis Biomedical	Outperform Votes 9 37.50%	Underperform Votes 15 62.50%

Summary

Astrotech beats Talis Biomedical on 9 of the 14 factors compared between the two stocks.